1. Home
  2. RH vs GHRS Comparison

RH vs GHRS Comparison

Compare RH & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

N/A

Current Price

$133.78

Market Cap

2.2B

ML Signal

N/A

Logo GH Research PLC

GHRS

GH Research PLC

N/A

Current Price

$19.39

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RH
GHRS
Founded
1979
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
RH
GHRS
Price
$133.78
$19.39
Analyst Decision
Hold
Strong Buy
Analyst Count
20
10
Target Price
★ $164.41
$42.89
AVG Volume (30 Days)
★ 752.4K
323.5K
Earning Date
12-10-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.31
N/A
EPS
★ 2.36
N/A
Revenue
★ $1,193,046,000.00
N/A
Revenue This Year
$5.68
N/A
Revenue Next Year
$9.26
N/A
P/E Ratio
$57.18
★ N/A
Revenue Growth
★ 24.52
N/A
52 Week Low
$106.30
$12.04
52 Week High
$239.40
$31.44

Technical Indicators

Market Signals
Indicator
RH
GHRS
Relative Strength Index (RSI) 50.18 43.18
Support Level $123.55 $17.54
Resistance Level $137.90 $22.51
Average True Range (ATR) 8.20 1.26
MACD -0.28 0.18
Stochastic Oscillator 30.36 41.50

Price Performance

Historical Comparison
RH
GHRS

About RH RH

RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and has a growing presence in hospitality with 27 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across design subcategories (RH Estates and Waterworks, for example), and has recently broadened its addressable market via expansion abroad (currently, less than 10% of sales) and its World of RH digital platform (highlighting offerings outside of home furnishings).

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: